Neuroblastoma

Citations Over TimeTop 10% of 2021 papers

Abstract

The survival of patients with high-risk neuroblastoma has improved significantly with the use of intensive multimodality treatment regimens, including chemotherapy, surgery, radiation therapy, myeloablative chemotherapy followed by stem cell rescue, and immunotherapy. This report summarizes the current treatment strategies used in the COG and SIOP for children with neuroblastoma. The improved global collaboration and the adoption of a uniform International Neuroblastoma Risk Group Staging System will help facilitate comparison of homogeneous pretreatment cohorts across clinical trials. Future research strategies regarding the indications for and dosages of radiation therapy to the primary and metastatic sites, and the integration of meta-iodobenzyl guanidine therapy into the multimodal treatment program, are discussed.

Related Papers

• → The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma(2006)88 cited
• → The Characteristics of Mediastinal Neuroblastoma(2000)40 cited
• → Low complex ganglioside expression characterizes human neuroblastoma cell lines(2005)38 cited
• → Excretion of catecholamines, their precursors and metabolites in patients with neuroblastoma and Ewing's tumour(1978)1 cited
• Current Clinical Trials in Neuroblastoma(2002)